Figure 1From: The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic ratsDiagram for animal treatments. Diagram of the different designed rat groups, both in control conditions or after diabetes mellitus induced by i.p. administration of streptozotocin (STZ). The animals received further i.p. administration of saline and/or anakinra (AK) before sacrifice in day 15.Back to article page